Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...

"But narrowing these benefits down to a single amino acid gets us closer to understanding the biological processes and maybe potential interventions for humans, like an isoleucine-blocking drug." ...

New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism — a novel genomically recoded organism ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and lymphatic tissue (mesenchymal cells). Despite being widely ...